Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the maximum amount of development and regulatory milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationMaximumDevelopmentAndRegulatoryMilestonePaymentsBasedOnRespectiveThresholdsOfNetSalesOfProducts
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the maximum amount of sales milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationMaximumSalesMilestonePaymentsBasedOnRespectiveThresholdsOfNetSalesOfProducts
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the number of development and regulatory milestone payments in asset acquisition.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationNumberOfDevelopmentAndRegulatoryMilestonePayments
Namespace Prefix:	zura_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of contingent payments due.

+ References

No definition available.

+ Details

Name:	zura_ContingentPaymentDue
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The period for payment of milestone payment.

+ References

No definition available.

+ Details

Name:	zura_PeriodForPaymentOfMilestonePayment
Namespace Prefix:	zura_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=zura_LicenseAgreementWithLillyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetAcquisitionAxis=zura_StonePeachPropertiesLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=zura_Baffx17LtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License Agreements - 2023 Lilly License (Details) - License agreement with Lilly $ in Millions	Apr. 26, 2023 USD ($) payment	Jun. 30, 2026 USD ($)	Dec. 08, 2022 USD ($)
License Agreements
Maximum amount of development and regulatory milestone payments			$ 155.0
Maximum amount of sales milestone payments			$ 440.0
Contingent payments due		$ 0.0
Stone Peach Properties, LLC
License Agreements
Contingent payments due		$ 0.0
BAFFX17, Ltd
License Agreements
Number of development and regulatory milestone payments \| payment	4
Maximum amount of development and regulatory milestone payments	$ 155.0
Maximum amount of sales milestone payments	$ 440.0
Period for payment of milestone payment	12 years